Novartis' Pluvicto is expected to dominate the market for radioligand therapies for prostate cancer, with ...

Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...

Switzerland’s financial-markets regulator ordered an audit of Credit Suisse’s actions that led to its collapse in March 2023, ...

The U.S. Food and Drug Administration has approved Indianapolis-based Eli Lilly's new treatment for moderate to severe eczema ...